(Q44704691)

5 December 2017

title

Gender and the use of neuroleptics in schizophrenia (English)

1 reference

5 December 2017

0 references

Raimo K. R. Salokangas

series ordinal

1

object named as

Raimo K R Salokangas

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

5 December 2017

number of pages

9

1 reference

inferred from page(s)

published in

Schizophrenia Research

1 reference

5 December 2017

volume

66

1 reference

5 December 2017

issue

1

1 reference

5 December 2017

page(s)

41-49

1 reference

Pituitary-ovarian relationships in women approaching the menopause

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900530-3

7 January 2021

Gender differences in age at onset of schizophrenia. An overview

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900530-3

7 January 2021

Gender differences in schizophrenia: rehospitalization and community survival.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900530-3

7 January 2021

14-year outcome in early schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900530-3

7 January 2021

Deficit and nondeficit forms of schizophrenia: the concept

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900530-3

7 January 2021

Hormonal changes and sexual function in aging men

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900530-3

7 January 2021

The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900530-3

7 January 2021

How does gender influence age at first hospitalization for schizophrenia? A transnational case register study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900530-3

7 January 2021

Oestradiol enhances the vulnerability threshold for schizophrenia in women by an early effect on dopaminergic neurotransmission. Evidence from an epidemiological study and from animal experiments

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900530-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900530-3

7 January 2021

Determinants of smoking behaviour in outpatients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900530-3

7 January 2021

Deinstitutionalization and schizophrenia in Finland II: discharged patients and their psychosocial functioning

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900530-3

7 January 2021

Prevalence of smoking among psychiatric outpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900530-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900530-3

7 January 2021

Effects of smoking on haloperidol and reduced haloperidol plasma concentrations and haloperidol clearance

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900530-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900530-3

7 January 2021

Effects of chronic neuroleptic administration on the hypothalamo-pituitary-gonadal axis of male schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900530-3

7 January 2021

Estimation of the distribution of age at natural menopause from prevalence data

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900530-3

7 January 2021

Psychopathology and violence: a review of literature

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900530-3

7 January 2021

Smoking and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900530-3

7 January 2021

Striatal dopamine transporters and cognitive functioning in healthy men and women

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900530-3

7 January 2021

Sex differences in human brain morphometry and metabolism: an in vivo quantitative magnetic resonance imaging and positron emission tomography study on the effect of aging.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900530-3

7 January 2021

Schizophrenia and oestrogens--is there an association?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900530-3

7 January 2021

Prognostic implications of the sex of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900530-3

7 January 2021

Gender and the use of neuroleptics in schizophrenia. Further testing of the oestrogen hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900530-3

7 January 2021

Deinstitutionalization and schizophrenia in Finland: I. Discharged patients and their care.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900530-3

7 January 2021

Gender and short-term outcome in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900530-3

7 January 2021

Effect of smoking on neuroleptics in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900530-3

7 January 2021

Early manifestations and first-contact incidence of schizophrenia in different cultures. A preliminary report on the initial evaluation phase of the WHO Collaborative Study on determinants of outcome of severe mental disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900530-3

7 January 2021

Long-term stability of neurotransmitter activity investigated with 11C-raclopride PET.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900530-3

7 January 2021

Interaction of sex, age, and neuroleptic dose

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900530-3

7 January 2021

Current outcome in schizophrenia: women vs men

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900530-3

7 January 2021

The role of estrogens in schizophrenia gender differences

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900530-3

7 January 2021

The natural history of schizophrenia: a five-year follow-up study of outcome and prediction in a representative sample of schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900530-3

7 January 2021

Hormonal characteristics of the human menstrual cycle throughout reproductive life

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900530-3

7 January 2021

Declining testicular function with age. Hormonal and clinical correlates

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900530-3

7 January 2021

Gender differences in living conditions found among male and female schizophrenic patients on a follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900530-3

7 January 2021

CSF biochemistries, glucose metabolism, and diurnal activity rhythms in alcoholic, violent offenders, fire setters, and healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900530-3

7 January 2021

10.1016/S0920-9964(02)00530-3

Identifiers

DOI

1 reference

5 December 2017

1 reference